Iron: Mammalian defense systems, mechanisms of disease, and chelation therapy approaches
The DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.
Abstract
During the past 6 decades, much attention has been devoted to understanding the uses, metabolism and hazards of iron in living systems. A great variety of heme and non-heme iron-containing enzymes have been characterized in nearly all forms of life. The existence of both ferrous and ferric ions in low- and high-spin configuration, as well as the ability of the metal to function over a wide range of redox potentials, contributes to its unique versatility. Not surprisingly, the singular attributes of iron that permit it to be so useful to life likewise render the metal dangerous to manipulate and to sequester. All vertebrate animals are prone to tissue damage from exposure to excess iron. In order to protect them from this threat, a complex system has evolved to contain and detoxify this metal. This is known as the iron withholding defense system, which mainly serves to scavenge toxic quantities of iron and also for depriving microbial and neoplastic invaders of iron essential for their growth. Since 1970, medical scientists have become increasingly aware of the problems involved in cellular iron homeostasis and of the disease states related to its malfunctioning. Scores of studies have reported that excessive iron in specific tissue sites is associated with development of infection, neoplasia, cardiomyopathy, arthropathy and a variety of endocrine and neurologic deficits. Accordingly, several research groups have attempted to develop chemical agents that might prevent and even eliminate deposits of excess iron. A few of these drugs now are in clinical use, e.g. deferiprone (L1). In the present review, we focus on recent developments in (i) selected aspects of the iron withholding defense system, and (ii) pharmacologic methods that can assist the iron-burdened patient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated Mø express and release lactoferrin, which scavenges and restricts Fe availability to extracellular pathogens [6,117,118] (Fig 2).Lactoferrin also protects Mø from oxidative stress [117,119] and modulates Mø microbicidal activity, as shown in the context of Staphylococcus aureus infection [120,121].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [118]
In the citing paper
“This glycoprotein secreted by macrophages and polymorphonuclear cells (PMN) at mucosal surfaces binds Fe3+ with high affinity (KD ∼ 10−20 M) and in doing so restricts the virulence of a variety of extracellular pathogens (29–31).”
From Innate Nutritional Immunity (2018) · cites this paper as [31]
Citations
Cites
Free radicals, antioxidants, and human disease: where are we now?
Halliwell, B. B., Gutteridge, J. M. C., & Cross, C. E. (1992) · PubMed · Cited by 2,649
Salonen, J. T., Nyyssönen, K., Korpela, H., Tuomilehto, J., Seppänen, R., & Salonen, R. (1992) · Circulation · doi:10.1161/01.cir.86.3.803 · Cited by 1,284
Weinberg, E. D. (1978) · Microbiological Reviews · doi:10.1128/mmbr.42.1.45-66.1978 · Cited by 1,254
Self-citationThelander, L., & Reichard, P. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.001025 · Cited by 1,167
Iron withholding: a defense against infection and neoplasia
Weinberg, E. D. (1984) · Physiological Reviews · doi:10.1152/physrev.1984.64.1.65 · Cited by 881
Self-citationIntramuscular desferrioxamine in patients with Alzheimer's disease
MCLACHLAN, D. (1991) · The Lancet · doi:10.1016/0140-6736(91)92978-b · Cited by 764
SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR
Zurlo, M., De Stefano, P., Borgna-Pignatti, C., Di Palma, A., Melevendi, C., Piga, A., Di Gregorio, F., Burattini, M., & Terzoli, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90264-x · Cited by 611
Nitrogen oxide levels in patients after trauma and during sepsis
OCHOA, J. B., UDEKWU, A. O., BILLIAR, T. R., CURRAN, R. D., CERRA, F. B., SIMMONS, R. L., & PEITZMAN, A. B. (1991) · Annals of Surgery · doi:10.1097/00000658-199111000-00013 · Cited by 599
Hibbs, J. B., Westenfelder, C., Taintor, R., Vavrin, Z., Kablitz, C., Baranowski, R. L., Ward, J. H., Menlove, R. L., McMurry, M. P., & Kushner, J. P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115666 · Cited by 485
Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions
Olivieri, N. F., Buncic, J. R., Chew, E., Gallant, T., Harrison, R. V., Keenan, N., Logan, W., Mitchell, D., Ricci, G., Skarf, B., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604033141402 · Cited by 429
Research works printed but not linked: 16
- Smith, 1981, Salivary lactoferrin in cystic fibrosis, Devel Biol Med, 9, 1040
- Ganeshaguru, 1992, Cytotoxic mechanisms of iron chelators, Drugs Today, 28, 29
- Kontoghiorghes, 1987, New synthetic approach and iron chelation studies of 1-alkyl-2methyl-3-hydroxypyrid-4-ones, Arz Forsch/Drug Res, 37, 1099
- Evans, 1992, The effect of alphaketohydroxypyridine chelators on transferrin saturation in vitro and in vivo, Drugs Today, 28, 19
- Sheppard, 1992, Synthesis and metabolism of L1 and other novel alpha-ketohydroxypyridine iron chelators and their metal complexes, Drugs Today, 28, 3
- 1980, 180, 1
- Nebeker, 1984, Aluminium related osteomalagia. Clinical response to desferrioxamine, Kidney Int, 25, 173
- Agarwal, 1992, Long-term assessment of efficacy and toxicity of L1 (1,2-dimethyl-3hydroxypyrid-4-one) in transfusion dependent thalassaemia. Indian trial, Drugs Today, 28, 107
- Khalifa, 1990, Salicyl-hydroxamic acid (SHAM); a new oral iron chelator for transfusion induced hemosiderosis in beta thalassaemia major, Blood, 76, 65a
- Brittenham, 1990, Pyridoxal isonicotinoyl hydrazone, an effective chelator after oral administration, Semin Haematol, 27, 112
- Kontoghiorghes, 1990, 1-Ethyl-2-methyl-3-hydroxypyrid-4-one (L1NEt). A new orally effective iron chelator for the treatment of transfusional iron overload, Blood, 76, 66a
- 1986, 6, 1
- Elorriaga, 1992, Aluminium removal: short- and long-term preliminary results with L1 in rats, Drugs Today, 28, 177
- Poltera, 1993, Desferal in human plasmodium Falciparum malaria, Plzen Lek Sborn Suppl, 68, 73
- Vreugdenhil, 1992, Iron and iron chelators in rheumatoid arthritis, Drugs Today, 28, 157
- Kontoghiorghes, 1992, Oral chelation in the treatment of thalassaemia and other diseases, Drugs Today, 28, 1
Cited by
Mycobacterium avium subsp.paratuberculosis in Veterinary Medicine
Harris, N. B., & Barletta, R. G. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.3.489-512.2001 · Cited by 597
“Cytokines may function by causing macrophages to actively limit their intracellular iron concentration in an attempt to restrict bacterial growth (172, 312).”
BackgroundKell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“Importantly, the comparatively weak bidentate binders seem not to have major long-term effects if used carefully [1325; 1591; 1615; 1616]”
BackgroundDe Voss, J. J., Rutter, K., Schroeder, B. G., Su, H., Zhu, Y., & Barry, C. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1252 · Cited by 532
Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense
Geiszt, M., Witta, J., Baff, J., Lekstrom, K., & Leto, T. L. (2003) · The FASEB Journal · doi:10.1096/fj.02-1104fje · Cited by 504
Krämer, J., Kang, R., Grimm, L. M., De Cola, L., Picchetti, P., & Biedermann, F. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00746 · Cited by 449
Metadata
- Authors
- Kontoghiorghes, G. J., & Weinberg, E. D.
- Affiliations
- University of London (GB)
- Indiana University Bloomington (US)
- Corresponding author
- Kontoghiorghes, G.J.
- ORCID
- Kontoghiorghes, G.J.
- Venue
- Blood Reviews
- Publisher
- Elsevier BV
- Published
- 1995-03
- Volume
- 9
- Issue
- 1
- Pages
- 33-45
- ISSN
- 0268-960X (ISSN-L)
- OpenAlex
- W2102967627
- Cited by
- 134
- References
- 133
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 6 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 1 · 2015: 4 · 2013: 3 · 2012: 3
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Blood Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- iron metabolism, iron overload, iron chelation therapy, cellular iron homeostasis, heme iron, non-heme iron, iron toxicity, iron deficiency, iron deficiency anemia
- MeSH terms
- Animals, Humans, Iron, Chelation Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Iron: Mammalian defense systems, mechanisms of disease, and chelation therapy approaches. https://app.cochat.ai/papers/10.1016/0268-960x(95)90038-1
- The paper
- Kontoghiorghes, G. J., & Weinberg, E. D. (1995). Iron: Mammalian defense systems, mechanisms of disease, and chelation therapy approaches. Blood Reviews. https://doi.org/10.1016/0268-960x(95)90038-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.